News

Philips Profit Plunges 85%, Adjusted Earnings Rise

+3

Finance

Philips Profit Plunges 85%, Adjusted Earnings Rise

Rachel Meyers · 2026-11-03T09:20:16.434Z

The adjusted numbers show real progress from cost cuts, but that recall provision wiped out most of the headline profit.

12 sourcesUpdated Nov 3, 20261 min read

+3

Philips Profit Plunges 85%, Adjusted Earnings Rise — Photo: Ceescamel / Wikimedia Commons (CC0)

Sponsored

Philips released third-quarter 2026 results on Nov. 3 with net income of €28 million, down from €187 million a year earlier, after booking a €288 million provision tied to an agreement in principle with the U.S. Department of Justice over the Respironics recall. Settlement payment is expected in the first quarter of 2027. Sales were €4.39 billion. Contested: a wire summary put comparable sales growth at 2%; other coverage put it at 3%. Comparable orders grew 8%. Adjusted EBITA rose to €569 million, with the margin up 70 basis points to 13.0%. The company kept its full-year 2026 outlook for comparable sales growth of 3% to 4.5% and an adjusted EBITA margin of 13.5% to 14%, and projected free cash flow of €1.5 billion to €1.7 billion. Personal Health posted 8% comparable sales growth and a 17.7% adjusted EBITA margin; Connected Care posted 5% and 13.3%. Shares rose more than 6% after the announcement. No other material factual disputes appear in the rated coverage. DOJ documentation remains to be finalized ahead of the expected Q1 2027 payment.

Sponsored

In this story:

Sponsored

How it spread

Broke Bloomberg · Nov 3, 1:14 AM ETLeft within the hourRight within the hourCenter +1h12 sources +3h on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

How each side headlines it

Left· 1 source

“Philips Profitability Beats Expectations on Cost Cutting, Sales”

Bloomberg · Nov 3, 2026

Center· 2 sources

“Philips jumps 6% on strong Q3 results”

Baha Breaking News · Nov 3, 2026

Right· 2 sources

“Philips Profit Plunges 85%, Adjusted Earnings Rise”

Independent Journal Review · Nov 3, 2026

Coverage

Sponsored

Comments (3)

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Derek Foss⚡51h
Sales growth is welcome, yet the Respironics costs prove how one product issue can drag on results for years.
Sam Okafor⚡61h
They stuck with the 2026 targets even after the settlement hit, which suggests management sees a clear path forward.
Rachel Meyers⚡141h
The adjusted numbers show real progress from cost cuts, but that recall provision wiped out most of the headline profit.

Sponsored

More on this story

Back to News

Finance

Raleigh Capital Boosts One Bond ETF Stake by 456 Percent

Raleigh Capital Management made varied third-quarter changes to its SPDR ETF holdings, sharply increasing its position in the aggregate bond ETF and opening new positions in emerging-markets bond and equity ETFs and an international small-cap ETF. It also cut its stake in the high-yield bond ETF by 77.5%.

46 sources

Finance

Surge Components Short Interest Falls 70% in October

October short-interest reports showed sharply different moves: short positions fell 83.8% for B.O.S. Better Online Solutions and 70.2% for Surge Component, while short interest in Innovator’s Daily PutWrite ETF rose 320%.

795 sources

Sponsored

Finance

Five Stocks’ Short Interest Jumps Up to 629%

Short interest increased in October across all five companies: Perimeter Medical Imaging AI rose the most, up 628.8%, followed by Arcadia Biosciences (286.3%), Regentis Biomaterials (223.8%), PIMCO Income Strategy Fund (139.3%) and Bumrungrad Hospital (118.3%). Arcadia had the highest reported share of stock sold short, at 14.9%.

596 sources